According to a new report, published by KBV research, The Global Clinical Trials Matching Software Market size is expected to reach $362.7 million by 2030, rising at a market growth of 13.5 % CAGR during the forecast period.
The Web & Cloud-based segment is generating the highest revenue in the Global Clinical Trials Matching Software Market, by Deployment Mode in 2022; thereby, achieving a market value of $334.7 million by 2030. Web and cloud-based deployment in the clinical trials matching software market offers several advantages, making it an attractive option for providers and users. Clinical trials matching software helps connect eligible patients with appropriate clinical trials, streamlining recruitment. Web and cloud-based solutions are accessible from anywhere with an internet connection, allowing healthcare providers, researchers, and patients to access the software from their preferred devices, including desktop computers, laptops, tablets, and smartphones.
The CROs segment would register a CAGR of 13.6% during (2023 - 2030). CROs provide drug development, commercialization, pharmaceutical surveillance, and post-approval services to companies with limited R&D expenditures. A sponsor contracts a CRO for clinical trials on a project-by-project basis. Consequently, the demand for CROs is significantly increasing. Finding suitable patients can be difficult and time-consuming during clinical investigations. Patients are recruited after screening or locating potential participants who fulfill the requirements, considering every aspect of the studies, ensuring awareness, and obtaining informed consent to participate.
The North America region dominated the Global Clinical Trials Matching Software Market, by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $177.5 million by 2030. The Europe market is anticipated a CAGR of 13.2% during (2023 - 2030). Additionally, The Asia Pacific market would exhibit a CAGR of 14.5% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/clinical-trials-matching-software-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Clario, IBM Corporation, Antidote Technologies, Inc., Ofni Systems Inc., Advarra, Inc., ArisGlobal LLC (Nordic Capital Limited), Teckro, Inc., BSI Business Systems Integration AG, Clinical Trials Mobile Application, Optimapharm d.o.o.
By Deployment Mode
By End-use
By Geography
Companies Profiled
Unique Offerings 
